pyronaridine has been researched along with Ebola Hemorrhagic Fever in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anantpadma, M; Comer, JE; Davey, RA; Ekins, S; Freundlich, JS; Lane, TR; Madrid, PB; Massey, C | 1 |
| Anantpadma, M; Comer, JE; Davey, RA; Dyall, J; Ekins, S; Freiberg, AN; Holbrook, MR; Lane, TR; Madrid, PB; Massey, C; Zhou, H | 1 |
2 other study(ies) available for pyronaridine and Ebola Hemorrhagic Fever
| Article | Year |
|---|---|
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
Topics: Animals; Antimalarials; Antiviral Agents; Cytokines; Drug Repositioning; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Humans; Male; Mice; Mice, Inbred BALB C; Naphthyridines | 2019 |
Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Drug Repositioning; Ebolavirus; Female; Guinea Pigs; Hemorrhagic Fever, Ebola; Humans; Inhibitory Concentration 50; Male; Marburgvirus; Mice; Microsomes; Naphthyridines | 2020 |